WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022

Jul 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-06-30

Reporting Person: Joseph Molly (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-30	Phantom Stock Unit	$	A	74.00	Acquired		Common Stock (74.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	308.00	Direct

Footnotes

F1: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.